Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FPW9Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,961
Award facts
- Contract value 100% obligated
- $14,961.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,961.06 on January 9, 2026, for the supply of Repatha 140 mg/mL SureClick (an injectable medication for cholesterol management) by the Defense Logistics Agency. The contract is classified as firm fixed price with no set-aside designation, indicating it was competitively awarded. The ultimate completion date is January 12, 2026, with the place of performance located at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen's role as a prime vendor through this IDC demonstrates the Defense Logistics Agency's reliance on established pharmaceutical distributors to supply critical medications to military treatment facilities and defense healthcare systems worldwide. The company's extensive contract portfolio with DLA reflects its capability to efficiently fulfill federal medical supply requirements across multiple therapeutic domains, including specialty medications and brand-name drugs necessary to support the Defense Health Agency and other government healthcare organizations. The non-set-aside nature of this award and the company's competitive positioning underscore its status as a qualified vendor capable of meeting federal procurement standards for pharmaceutical delivery.
Quick answers
Who was awarded contract SPE2DR26FPW9Y?
SPE2DR26FPW9Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FPW9Y worth?
The government has obligated $14,961 on SPE2DR26FPW9Y.
Is contract SPE2DR26FPW9Y an order under another contract?
Yes. SPE2DR26FPW9Y is a delivery order under SPE2DR25D1034, an indefinite delivery contract.
Was contract SPE2DR26FPW9Y competed?
The extent of competition for SPE2DR26FPW9Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award